Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Van

Showing results (21-30 of 437) with videos related to

Pageof 44
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|June 15, 1996
[Immunotherapy in rheumatoid arthritis; current status]F C Breedveld, L B van de Putte
Agents and Actions. Supplements|January 1, 1979
Proliferative lesion of arthritis: a target for therapy?L B Van De Putte, H J Van Beusekom
The Netherlands Journal of Medicine|June 1, 1990
Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challengeP L van Riel, L B van de Putte
Nederlands Tijdschrift Voor Geneeskunde|February 4, 2005
[Diagnostic image (222). A boy with backache and loss of neurological function]L B van der Mark, A M van Furth
The Journal of Rheumatology. Supplement|September 1, 1994
DC-ART: what proportion of response constitutes a positive response?P L van Riel, L B van de Putte
Clinical and Experimental Rheumatology|May 1, 1997
Currently used second-line agents: do they control the disease course?L B van de Putte, P L van Riel
Nederlands Tijdschrift Voor Geneeskunde|April 8, 1989
[Slow-acting antirheumatic agents]L B van de Putte, P L van Riel
Zeitschrift Fur Rheumatologie|December 29, 1998
[Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion proteins (TNFR55-IgG1)--results of double-blind placebo-controlled studies over 3 months]L B van de Putte, O Sander, R Rau
Clinical and Experimental Rheumatology|September 1, 1995
Rheumatoid arthritis: new trends in therapyL B van de Putte, P L van Riel
Current Opinion in Rheumatology|March 1, 1994
Clinical assessment and clinical trials in rheumatoid arthritisP L van Riel, L B van de Putte
Pageof 44

Showing results (21-30 of 437) with videos related to

Sort By:
Pageof 44
Nederlands Tijdschrift Voor Geneeskunde|June 15, 1996
[Immunotherapy in rheumatoid arthritis; current status]F C Breedveld, L B van de Putte
Agents and Actions. Supplements|January 1, 1979
Proliferative lesion of arthritis: a target for therapy?L B Van De Putte, H J Van Beusekom
The Netherlands Journal of Medicine|June 1, 1990
Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challengeP L van Riel, L B van de Putte
Nederlands Tijdschrift Voor Geneeskunde|February 4, 2005
[Diagnostic image (222). A boy with backache and loss of neurological function]L B van der Mark, A M van Furth
The Journal of Rheumatology. Supplement|September 1, 1994
DC-ART: what proportion of response constitutes a positive response?P L van Riel, L B van de Putte
Clinical and Experimental Rheumatology|May 1, 1997
Currently used second-line agents: do they control the disease course?L B van de Putte, P L van Riel
Nederlands Tijdschrift Voor Geneeskunde|April 8, 1989
[Slow-acting antirheumatic agents]L B van de Putte, P L van Riel
Zeitschrift Fur Rheumatologie|December 29, 1998
[Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion proteins (TNFR55-IgG1)--results of double-blind placebo-controlled studies over 3 months]L B van de Putte, O Sander, R Rau
Clinical and Experimental Rheumatology|September 1, 1995
Rheumatoid arthritis: new trends in therapyL B van de Putte, P L van Riel
Current Opinion in Rheumatology|March 1, 1994
Clinical assessment and clinical trials in rheumatoid arthritisP L van Riel, L B van de Putte
Pageof 44